Novel laser device effective for nasal telangiectasia treatment

Novel laser device effective for nasal telangiectasia treatment
(HealthDay)—The TRASER (Total Reflection Amplification of Spontaneous Emission Radiation) device is a safe and effective option for treatment of nasal telangiectasias, according to a small study published online April 6 in Lasers in Surgery and Medicine.

Paul M. Friedman, M.D., from the Dermatology and Laser Surgery Center in Houston, and colleagues evaluated the safety and efficacy of a novel configurable device in the treatment of nasal telangiectasias among 15 (aged 42 years) with Fitzpatrick skin types I and II. Efficacy was measured by blinded analysis of before and after (30 days) images and self-assessment by the subjects.

The researchers found that based on the 13 patients who completed the study, all achieved procedure success (defined as a 2-point improvement on the 5-point Telangiectasia Scale) at the end of the final treatment. In more than 75 percent of patients, a single was effective, with at least a 75 percent reduction in blood vessels. Larger vessels responded well to longer pulse durations (40 milliseconds), while smaller vessels responded best to shorter pulse durations (25 milliseconds). No serious adverse events were reported.

"These treatments were well tolerated and provided high patient satisfaction," the authors write.

Several authors disclosed financial ties to Solta Medical.


Explore further

Thulium fiber laser rejuvenates male scalp with photodamage

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Novel laser device effective for nasal telangiectasia treatment (2017, April 11) retrieved 18 January 2019 from https://medicalxpress.com/news/2017-04-laser-device-effective-nasal-telangiectasia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more